Steve Brozak (born 1961) is the Managing Partner and President of WBB Securities, LLC, a Democratic congressional candidate in the 2004 American election cycle, and was the Chairman and CEO of StormBio, Inc. Brozak was named a 2013 StarMine "Top Stock Picker" among Pharmaceutical Analysts by the Thomson Reuters Awards for Excellence, and was recognized by The Wall Street Journal as "Best on the Street" among Medical Equipment and Supplies financial analysts. Brozak is a retired Lieutenant Colonel in the United States Marine Corps. He served a three-year appointment to the Secretary of Navy's Navy and Marine Corps Retiree Council. He also is a Fellow of Foreign Policy Association. Education Brozak received his BA from Columbia University (1982), MBA from Columbia Business School (1994) and Doctor of Medical Humanities (DMH) from Drew University (2016). Career Brozak is the President and Co-founder of WBB Securities, LLC, an independent broker dealer, investment bank and sell-side research firm. WBB Securities focuses on healthcare, biotechnology, pharmaceutical and medical device research and banking. WBB Securities and its analysts are ranked consistently as top performers in research accuracy. In September 2016, WBB Securities added an asset management arm to the firm, which subsequently launched a long/short equity healthcare fund named WBB Life Sciences l/s. As president of WBB Securities, Brozak is responsible for the research and investment banking division. He raises funds for public offerings in various healthcare sectors. He has been ranked one of the top analysts of all First Call submitting analysts in all healthcare sectors over the past five years by the StarMine ranking system. In 2010, he was named one of the Top Analysts in the Healthcare Sector for the United States by the Financial Times and StarMine. As being named 2013 StarMine "top stock picker" among Pharmaceutical Analysts, Brozak has achieved top-ranking recognition in all healthcare fields including Biotechnology, Medical Devices, and Pharmaceuticals over the last five years by the Thomson Reuters Awards for Excellence and The Wall Street Journal Best on the Street Survey. He is a Fellow of the Foreign Policy Association. Brozak has specific expertise and interest in human stem cell therapies, biothreat countermeasures, bacterium, and viruses such as highly pathogenic influenza, Marburg, and Ebola. He is a contributor to Forbes, Businessweek, STAT, CNN, and ABCNews.com while regularly authoring articles in peer-reviewed and news publications. Among articles are: "How Mental Health Is Shortchanged by Lack of Reimbursement for